Kezar Life Sciences Inc (KZR)

Apr 14, 2026

How activist investor Kevin Tang finally landed the Bay Area company that got away from him - The Business Journals

Apr 14, 2026

Apr 14, 2026

Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders? - Benzinga

Apr 14, 2026

Apr 14, 2026

M&A Class Action Firm Investigating Multiple Mergers - National Today

Apr 14, 2026

Apr 14, 2026

Aurinia to Acquire Kezar (NASDAQ: KZR) for $6.955 Cash plus CVR - Stock Titan

Apr 14, 2026

Apr 13, 2026

Aurinia to buy Kezar (KZR) for $6.955/Share plus CVR (7.39M shares) - Stock Titan

Apr 13, 2026

Apr 12, 2026

Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN

Apr 12, 2026

Apr 12, 2026

Working capital per share of Kezar Life Sciences Inc – FWB:2KZ0 - TradingView — Track All Markets

Apr 12, 2026

Apr 12, 2026

KZR Technical Analysis & ETF Price Forecast - Intellectia AI

Apr 12, 2026

Apr 11, 2026

Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN

Apr 11, 2026

Apr 10, 2026

Finance Watch: Replimune Cutting Jobs As FDA Rejects RP1 A Second Time - Citeline News & Insights

Apr 10, 2026

Apr 10, 2026

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? - GuruFocus

Apr 10, 2026

Apr 10, 2026

Weekly Trades: Will Kezar Life Sciences Inc announce a stock splitInsider Buying & Safe Swing Trade Setups - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat

Apr 10, 2026

Apr 09, 2026

Published on: 2026-04-10 03:01:28 - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Sectors Review: What are Kezar Life Sciences Incs recent SEC filings showing2026 Short Interest & Reliable Trade Execution Plans - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - Sahm

Apr 09, 2026

Apr 09, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS - Sahm

Apr 09, 2026

Apr 08, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—KZR, CNTA, AFBI, and APLS - Morningstar

Apr 08, 2026

Apr 08, 2026

Growth Value: Does Kezar Life Sciences Inc meet Warren Buffetts criteria2026 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? - Finviz

Apr 07, 2026

Apr 07, 2026

Pullback Watch: What is the next catalyst for Kezar Life Sciences Inc2026 Fed Impact & Precise Entry and Exit Recommendations - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Shareholder Alert: Ademi LLP investigates whether Kezar - GlobeNewswire

Apr 07, 2026

Apr 06, 2026

Baselake reports 5.3% stake in Kezar Life Sciences (NASDAQ: KZR) - Stock Titan

Apr 06, 2026

Apr 06, 2026

Does Kezar Life Sciences Inc meet Warren Buffetts criteria2026 Volatility Report & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Aurinia Pharmaceuticals acquiring Kezar Life Sciences - msn.com

Apr 06, 2026

Apr 04, 2026

KZR Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Kezar Life Sciences Announces Lease Termination and Executive Separation Agreements in April 2026 - Minichart

Apr 04, 2026

Apr 04, 2026

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger Deal - Minichart

Apr 04, 2026

Apr 04, 2026

KZR PE Ratio & Valuation, Is KZR Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Kezar Life Sciences announces lease termination and executive departures following merger agreement - Investing.com South Africa

Apr 03, 2026

Apr 03, 2026

Kezar Life Sciences Announces Major Executive Leadership Changes - TipRanks

Apr 03, 2026

Apr 03, 2026

Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline - TipRanks

Apr 03, 2026

Apr 03, 2026

Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs - Stock Titan

Apr 03, 2026

Apr 03, 2026

Kezar Life Sciences' Christopher J. Kirk, Marc L. Belsky and Mark Schiller to Depart under Separation Agreements - TradingView — Track All Markets

Apr 03, 2026

Apr 03, 2026

Aurinia to acquire Kezar (NASDAQ: KZR) for $6.955 cash plus CVR - Stock Titan

Apr 03, 2026

Apr 03, 2026

Kezar Life Sciences, Inc. Announces Resignation of Mark Schiller as Chief Operating Office - marketscreener.com

Apr 03, 2026

Apr 01, 2026

Major Kezar (KZR) shareholder signs merger support pact and drops bid - Stock Titan

Apr 01, 2026

Mar 31, 2026

Aurinia Pharmaceuticals: $6.955 Per Share Acquisition Of Kezar Life Sciences To Expand Autoimmune Pipeline - Pulse 2.0

Mar 31, 2026

Mar 31, 2026

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Zenopa

Mar 31, 2026

Mar 31, 2026

Trend Recap: What is Kezar Life Sciences Incs market position2026 Chart Watch & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Aurinia to acquire Kezar Life Sciences - The Pharma Letter

Mar 31, 2026

Mar 31, 2026

Jefferies maintains Kezar Life Sciences stock rating on acquisition By Investing.com - Investing.com India

Mar 31, 2026

Mar 30, 2026

KZR Acquisition by Aurinia Pharmaceuticals Valued at $6.955 per Share - GuruFocus

Mar 30, 2026

Mar 30, 2026

Aurinia to Acquire Kezar Life Sciences (KZR) in Cash Deal - GuruFocus

Mar 30, 2026

Mar 30, 2026

Aurinia to Acquire Kezar Life Sciences (KZR) in Strategic Deal - GuruFocus

Mar 30, 2026

Mar 30, 2026

Jefferies maintains Kezar Life Sciences stock rating on acquisition - Investing.com

Mar 30, 2026

Mar 30, 2026

After failed takeover bid, activist investor finds new way to buy out Bay Area company - The Business Journals

Mar 30, 2026

Mar 30, 2026

Aurinia Pharma U.S., Inc. agreed to acquire Kezar Life Sciences, Inc. for $51 million. - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Shareholder Alert: The Ademi Firm investigates whether Kezar Lif - GuruFocus

Mar 30, 2026

Mar 30, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR) - PR Newswire

Mar 30, 2026

Mar 30, 2026

US Market Wrap: Does Kezar Life Sciences Inc meet Warren Buffetts criteria2026 Macro Moves & Consistent Return Investment Signals - baoquankhu1.vn

Mar 30, 2026